SinoMab BioScience Limited (3681.HK)

HKD 1.58

(0.0%)

Net Debt Summary of SinoMab BioScience Limited

  • SinoMab BioScience Limited's latest annual net debt in 2023 was 247.14 Million CNY , up 2054.51% from previous year.
  • SinoMab BioScience Limited's latest quarterly net debt in 2024 Q2 was 270.16 Million CNY , down 0.0% from previous quarter.
  • SinoMab BioScience Limited reported annual net debt of 11.47 Million CNY in 2022, up 103.99% from previous year.
  • SinoMab BioScience Limited reported annual net debt of -287.52 Million CNY in 2021, up 59.65% from previous year.
  • SinoMab BioScience Limited reported quarterly net debt of 247.14 Million CNY for 2023 FY, up 2054.51% from previous quarter.
  • SinoMab BioScience Limited reported quarterly net debt of 247.14 Million CNY for 2023 Q4, down 0.0% from previous quarter.

Annual Net Debt Chart of SinoMab BioScience Limited (2023 - 2017)

Created with Highcharts 11.1.0YearsNet Debt2017201820192020202120222023-1500000000 HKD-1000000000 HKD-500000000 HKD0 HKD500000000 HKD

Historical Annual Net Debt of SinoMab BioScience Limited (2023 - 2017)

Year Net Debt Net Debt Growth
2023 247.14 Million CNY 2054.51%
2022 11.47 Million CNY 103.99%
2021 -287.52 Million CNY 59.65%
2020 -712.53 Million CNY 37.89%
2019 -1.14 Billion CNY -6217.06%
2018 18.75 Million CNY -87.14%
2017 145.88 Million CNY 0.0%

Peer Net Debt Comparison of SinoMab BioScience Limited

Name Net Debt Net Debt Difference
Uni-Bio Science Group Limited -76.36 Million HKD 423.618%
CK Life Sciences Int'l., (Holdings) Inc. 5.26 Billion HKD 95.308%